• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » C.R. Bard posted major profit growth in its 1st quarter | Medtech Wall Street news for the week of Apr. 28, 2014

C.R. Bard posted major profit growth in its 1st quarter | Medtech Wall Street news for the week of Apr. 28, 2014

May 1, 2014 By MassDevice Contributors Network

C.R. Bard blows away sales and earnings expectations in Q1

April 25, 2014 by Arezu Sarvestani

C.R. Bard blows away sales and earnings expectations in Q1

Healthcare giant C.R. Bard posted major profit growth in its 1st quarter, beating Wall Street’s expectations with its adjusted per-share earnings.

The Murray Hill, N.J., company’s profits gained 63.6% year-over-year, and its adjusted EPS of $1.91 beat analysts’ consensus estimate by 6¢. Read more

Zimmer beats The Street, alters 2014 forecast on Biomet buy

April 24, 2014 by Arezu Sarvestani

Zimmer beats The Street, lowers forecast on Biomet buy

Zimmer turned a lot of heads today with news of its $13.35 billion mega-offer for fellow orthopedics giant Biomet, with little love lost over a lowered per-share forecast for the rest of the year.

The company announced the Biomet buy in parallel with news of its latest quarter, in which sales rose 2% and profits gained about 1.3%. Zimmer’s adjusted Q1 earnings amounted to $1.50 per share, beating expectations by about 3¢. Read more

Vascular Solutions lowers 2014 forecast on higher legal fees

April 24, 2014 by Arezu Sarvestani

Vascular Solutions dips again on missed Q1 earnings

Vascular Solutions wasn’t making friends on Wall Street this week after the company missed expectations for Q1 and lowered its forecast for the rest of the year.

Even with a 31.7% boost in profits year-over-year, the Minneapolis company missed projections by 2¢. VASC shares dropped more than 5% after the company released its earnings on Tuesday, closing at $22.92 last night. Read more

Lombard Medical sinks on IPO day | MassDevice.com On Call

April 28, 2014 by Arezu Sarvestani

MassDevice.com On Call

MASSDEVICE ON CALL — London medtech maker Lombard Medical Technologies had a lackluster 1st day on the Nasdaq stock exchange, with its new EVAR shares opening flat and losing 9% by the end of the day.

The EVAR stock opened at $11 and closed at $10 on Friday, marking another dim development for the company’s troubled IPO efforts. Read more

Edwards Lifesciences' Sapien sales grow 11.5% in Q1

April 25, 2014 by Arezu Sarvestani

TAVI: Edwards' Sapien sales gain 11.5% in Q1

Medtech giant Edwards Lifesciences posted Street-beating figures for its 1st quarter, driven largely by growth in its transcatheter heart valves.

Sales of its Sapien suite of valves grew 11.5% year-over-year, contributing to a 2.7% increase in adjusted per-share earnings, which beat analysts’ expectations by 7¢. Total revenues increased 5.3% during Q1, but fell just shy of analysts estimates. Read more

Filed Under: News Well, Wall Street Beat Tagged With: Biomet, C.R. Bard, Edwards Lifesciences, lombardmedical, vascularsolutions, Zimmer Biomet

More recent news

  • Autonomix picks up key nerve ablation catheter patent
  • Affluent Medical can move to pivotal phase of artificial urinary sphincter study
  • Globus Medical announces $500M share repurchase program
  • Cook Medical warns of issue with angiographic catheter
  • Virtuoso Surgical reports first cases with robotic endoscopy system, plans FDA IDE submission

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy